MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 05-23-2026
Chembio Diagnostics Total Shareholders Equity 2011-2026 | CEMI
Annual Total Shareholders Equity Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.8 M | 34.3 M | 27.8 M | 24 M | 33.3 M | 13.1 M | 17.2 M | 17.7 M | 19.7 M | 20.2 M | 13.9 M | 12.5 M | 5.81 M | 3.09 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 34.3 M | 3.09 M | 18.6 M |
Quarterly Total Shareholders Equity Chembio Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 17.8 M | 19.9 M | 26.5 M | 34.3 M | 47.9 M | 15.1 M | 23.3 M | 27.8 M | 33.9 M | 38.7 M | 18.1 M | 24 M | 25.8 M | 27.9 M | 31.1 M | 33.3 M | 19.7 M | 22 M | 23.8 M | 13.1 M | 14.9 M | 15.4 M | 17.4 M | 17.2 M | 19.6 M | 9.16 M | 17.4 M | 17.7 M | 18.2 M | 18.6 M | 19.2 M | 19.7 M | 20.1 M | 20.3 M | 20.2 M | 20.2 M | 20.4 M | 19.6 M | 14.3 M | 13.9 M | 13.3 M | 13.5 M | 13.1 M | 12.5 M | 6.75 M | 6.2 B | 12.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.2 B | 6.75 M | 152 M |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
27.5 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.17 B | $ 203.74 | 0.78 % | $ 22.6 B | USA |
 |
Celcuity
CELC
|
101 M | $ 87.89 | -0.4 % | $ 4.11 B | USA |
|
Akumin
AKU
|
-48.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
20.6 M | $ 3.87 | 2.38 % | $ 5.15 M | USA |
 |
Castle Biosciences
CSTL
|
471 M | $ 20.89 | 1.11 % | $ 606 M | USA |
 |
Aspira Women's Health
AWH
|
-6.93 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-56 M | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
1.11 B | $ 17.98 | -2.02 % | $ 553 M | USA |
 |
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
-99.3 M | $ 131.24 | 1.09 % | $ 16.5 B | USA |
 |
CareDx, Inc
CDNA
|
303 M | $ 24.68 | 2.49 % | $ 1.32 B | USA |
 |
Interpace Biosciences
IDXG
|
22.4 M | $ 1.71 | 8.57 % | $ 7.57 M | USA |
 |
Check-Cap Ltd.
CHEK
|
3.44 M | - | - | $ 9.42 M |  Israel |
 |
Illumina
ILMN
|
2.72 B | $ 166.32 | -0.34 % | $ 25.8 B | USA |
 |
ICON Public Limited Company
ICLR
|
9.19 B | $ 145.01 | -1.83 % | $ 11.4 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
1.83 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
548 M | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
14 M | $ 17.93 | -2.08 % | $ 401 M | USA |
 |
Lantheus Holdings
LNTH
|
1.09 B | $ 104.79 | 0.11 % | $ 7.07 B | USA |
 |
Natera
NTRA
|
1.71 B | $ 221.58 | 2.12 % | $ 30.3 B | USA |
 |
Charles River Laboratories International
CRL
|
3.16 B | $ 186.57 | -1.1 % | $ 9.25 B | USA |
 |
Pacific Biosciences of California
PACB
|
5.35 M | $ 1.38 | 4.73 % | $ 414 M | USA |
 |
Medpace Holdings
MEDP
|
459 M | $ 461.06 | -1.38 % | $ 13.3 B | USA |
 |
Mettler-Toledo International
MTD
|
-23.6 M | $ 1 156.94 | 0.2 % | $ 23.8 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
2.4 B | - | - | $ 19.8 B | USA |
 |
NeoGenomics
NEO
|
837 M | $ 10.95 | -1.26 % | $ 1.4 B | USA |
 |
Myriad Genetics
MYGN
|
368 M | $ 4.36 | 0.93 % | $ 404 M | USA |
 |
Personalis
PSNL
|
261 M | $ 10.1 | 3.17 % | $ 901 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
11 B | $ 26.89 | 0.73 % | $ 25.5 B |  Niderland |
 |
Senseonics Holdings
SENS
|
61 M | $ 7.29 | 0.62 % | $ 304 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.78 B | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
450 M | - | - | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
473 M | $ 84.5 | 4.59 % | $ 5.05 B | USA |
 |
Biomerica
BMRA
|
4.1 M | $ 1.92 | -4.01 % | $ 4.41 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.62 B | $ 265.28 | 0.14 % | $ 22.1 B | USA |
 |
Thermo Fisher Scientific
TMO
|
53.4 B | $ 474.98 | 0.29 % | $ 179 B | USA |
 |
Trinity Biotech plc
TRIB
|
-35.2 M | $ 0.6 | -12.08 % | $ 216 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
2.07 B | $ 9.46 | 1.72 % | $ 2.05 B | USA |
 |
Invitae Corporation
NVTA
|
102 M | - | - | $ 21.2 M | USA |